RecruitingNCT06256393

Inflammatory Bowel Disease Cohort in Nantes

Cohorte Nantaise de Maladies Inflammatoires Chroniques Intestinales


Sponsor

Nantes University Hospital

Enrollment

360 participants

Start Date

Feb 4, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study in Nantes, France, follows a large group of patients with inflammatory bowel disease (IBD) — including Crohn's disease, ulcerative colitis, and related conditions — over time. Researchers collect biological samples and clinical data to better understand the disease and improve treatment strategies. **You may be eligible if...** - You are over 18 with a confirmed diagnosis of Crohn's disease, ulcerative colitis, unclassified IBD, or refractory chronic pouchitis - You have active disease requiring surgery or an endoscopy procedure - You have signed informed consent and agreed to biological sample collection for research **You may NOT be eligible if...** - Your IBD is currently in remission (not active) - You have a contraindication to general anesthesia - You are a vulnerable person under legal protection (such as under guardianship) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCollection of biological samples

Collection of blood samples and intestinal biopsies during a surgery or colonoscopy for disease relapse


Locations(3)

CHU de Nantes

Nantes, France

Clinique Jules Verne

Nantes, France

Hopital Privé du Confluent

Nantes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06256393


Related Trials